FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
Clinical trial NCT06519370 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06519370
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-09
- Primary completion
- 2026-08-18
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.